Barclays »

Editas Medicine shares owned by Barclays

Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Editas Medicine

Tip: Access up to 7 years of quarterly data

All positions including Editas Medicine held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Editas Medicine by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.8M 279k 10.13
2023-09-30 $2.1M 275k 7.80
2023-06-30 $2.5M 299k 8.23
2023-03-31 $2.0M 275k 7.25
2022-12-31 $3.9M 440k 8.87
2022-09-30 $3.7M 300k 12.24
2022-06-30 $261k 22k 11.85
2022-03-31 $596k 31k 19.03
2021-12-31 $2.5M 95k 26.56
2021-09-30 $3.7M 91k 41.08
2021-06-30 $3.6M 64k 56.76
2021-03-31 $4.4M 105k 42.00
2020-12-31 $1.7M 24k 70.07
2020-09-30 $1.3M 47k 28.05
2020-06-30 $1.5M 51k 29.57
2020-03-31 $896k 45k 19.86
2019-12-31 $2.2M 74k 29.61
2019-09-30 $1.3M 55k 22.73
2019-06-30 $802k 32k 24.75
2019-03-31 $336k 14k 24.41
2018-12-31 $759k 33k 22.75
2018-09-30 $579k 18k 31.86
2018-06-30 $3.9M 110k 35.88
2018-03-31 $1.3M 40k 33.15
2017-12-31 $502k 16k 30.77
2017-09-30 $307k 13k 24.00
2017-06-30 $0 257 0.00
2017-03-31 $1.5M 67k 22.68
2016-12-31 $34k 2.1k 16.22
2016-09-30 $3.3k 144 23.26
2016-03-31 $824k 24k 33.99